| k | n | SMD (95% CIs) | p | I2 (%) |
---|---|---|---|---|---|
Overall | 81 | 956 | 0.15 [0.12, 0.18] | <0.001 | 6.4 |
Design | Â | Â | Qb: 2.37 | 0.121 | Â |
Crossover | 76 | 856 | 0.14 [0.11, 0.17] | <0.001 | 0 |
Parallel | 5 | 100 | 0.36 [0.08, 0.64] | 0.011 | 32 |
Blinding | Â | Â | Qb: 1.29 | 0.544 | Â |
Single blind | 8 | 77 | 0.11 [-0.002, 0.22] | 0.054 | 0 |
Double blind | 71 | 857 | 0.16 [0.12, 0.19] | <0.001 | 0 |
Unclear | 2 | 22 | 0.07 [-0.14, 0.29] | 0.519 | 60 |
Supplementation duration | Â | Â | Qb: 3.05 | 0.084 | Â |
Acute | 38 | 437 | 0.12 [0.06, 0.17] | <0.001 | 13 |
Multiple days | 43 | 519 | 0.18 [0.13, 0.22] | <0.001 | 9 |
Sex1 | Â | Â | Qb: 6.94 | 0.031 | Â |
Male | 59 | 658 | 0.16 [0.12, 0.20] | <0.001 | 0 |
Female | 4 | 48 | 0.0 [-0.12, 0.11] | 0.988 | 0 |
Mixed | 16 | 229 | 0.15 [0.09, 0.21] | <0.001 | 0 |
Performance level | Â | Â | Qb: 8.78 | 0.032 | Â |
PL12 | 1 | 14 | -0.29 [-0.69, 0.11] | 0.156 | - |
PL2 | 23 | 290 | 0.24 [0.12, 0.35] | <0.001 | 52 |
PL2 females | - | Â | Â | Â | Â |
PL2 males: | 17 | 181 | 0.24 [0.11, 0.36] | <0.001 | 52 |
GXT | 3 | 34 | 0.16 [-0.14, 0.46] | 0.300 | 80 |
IGXT | 1 | 14 | 0.22 [0.01, 0.44] | 0.040 | Â |
ITTE | 1 | 12 | 0.47 [0.03, 0.91] | 0.038 | Â |
TT | 4 | 47 | 0.01 [-0.28, 0.29] | 0.975 | 53 |
TTE | 8 | 74 | 0.39 [0.21, 0.57] | <0.001 | 27 |
PL3 | 15 | 154 | 0.18 [0.12, 0.24] | <0.001 | 0 |
PL3 females | - | Â | Â | Â | Â |
PL3 males: | 15 | 154 | 0.18 [0.12, 0.24] | <0.001 | 0 |
GXT | 2 | 17 | 0.1 [-0.27, 0.47] | 0.612 | 53 |
ITT | 2 | 20 | 0.17 [0, 0.35] | 0.592 | 0 |
TT | 8 | 82 | 0.17 [0.1, 0.24] | <0.001 | 0 |
TTE | 3 | 35 | 0.26 [-0.18, 0.69] | 0.249 | 71 |
PL4 | 8 | 87 | 0.03 [-0.14, 0.2] | 0.762 | 0 |
PL4 females | 1 | 14 | 0.02 [-0.37, 0.42] | 0.912 | - |
PL4 males: | 7 | 73 | 0.03 [-0.16, 0.22] | 0.787 | 0 |
GXT | 1 | 12 | 2.17 [-1.8, 6.14] | 0.289 | - |
TT | 6 | 61 | 0.02 [-0.17, 0.22] | 0.825 | 0 |
PL5 | 6 | 57 | -0.02 [-0.22, 0.17] | 0.821 | 0 |
PL5 females | 1 | 12 | -0.01 [-0.43, 0.42] | 0.980 | - |
PL5 males: | 5 | 45 | -0.03 [-0.25, 0.19] | 0.808 | 0 |
ITTE | 1 | 9 | -0.07 [-0.56, 0.42] | 0.801 | - |
TT | 4 | 36 | -0.02 [-0.27, 0.23] | 0.882 | 0 |
Exercise mode | Â | Â | Qb: 2.29 | 0.825 | Â |
Cycling | 53 | 625 | 0.17 [0.12, 0.22] | <0.001 | 22 |
Hand cycling | 4 | 39 | 0.02 [-0.21, 0.26] | 0.859 | 0 |
Incline walk/run | 1 | 14 | -0.29 [-0.69, 0.11] | 0.156 | - |
Kayaking | 2 | 14 | 0.13 [-0.02, 0.28] | 0.093 | 0 |
Rowing | 2 | 20 | 0.09 [-0.24, 0.42] | 0.604 | 0 |
Running | 15 | 196 | 0.14 [0.07, 0.21] | <0.001 | 19 |
Swimming | 4 | 48 | 0.12 [0.004, 0.23] | 0.042 | 0 |
Test type | Â | Â | Qb: 10.29 | 0.059 | Â |
GXT | 15 | 176 | 0.15 [0.02, 0.27] | 0.023 | 59 |
IGXT | 2 | 50 | 0.13 [0.03, 0.22] | 0.008 | 0 |
ITT | 4 | 44 | 0.13 [0.002, 0.27] | 0.046 | 0 |
ITTE | 2 | 21 | 0.21 [-0.02, 0.39] | 0.244 | 60 |
TT | 39 | 436 | 0.12 [0.07, 0.16] | <0.001 | 0 |
TTE | 19 | 229 | 0.31 [0.20, 0.42] | <0.001 | 29 |
Test duration | Â | Â | Qb: 2.89 | 0.577 | Â |
<5 mins: | 11 | 104 | 0.16 [0.08, 0.23] | <0.001 | 0 |
TT | 8 | 70 | 0.12 [0.04, 0.21] | 0.005 | 0 |
TTE | 3 | 34 | 0.32 [0.07, 0.56] | 0.011 | 29 |
5-10 mins: | 24 | 276 | 0.18 [0.09, 0.27] | <0.001 | 31 |
TT | 11 | 112 | 0.12 [0.02, 0.22] | 0.016 | 7 |
TTE | 13 | 164 | 0.29 [0.13, 0.44] | <0.001 | 40 |
10-30 mins: | 12 | 122 | 0.16 [0.04, 0.28] | 0.007 | 41 |
TT | 9 | 91 | 0.12 [-0.004, 0.23] | 0.058 | 41 |
TTE | 3 | 31 | 0.44 [0.16, 0.73] | 0.002 | 0 |
30-60 mins: | 5 | 60 | 0.08 [-0.11, 0.28] | 0.397 | 0 |
TT | 5 | 60 | 0.08 [-0.11, 0.28] | 0.397 | 0 |
>60 mins: | 4 | 51 | 0.00 [-0.21, 0.21] | 0.986 | 0 |
TT | 4 | 51 | 0.00 [-0.21, 0.21] | 0.986 | 0 |
Overall (TT & TTE) | 56 | 613 | 0.15 [0.11, 0.19] | <0.001 | 2 |